- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06324708
Analysis of Defined Elements on DXA in Patients Undergoing Hip Arthroplasty (THA_DXA)
Finite-element Analysis Based on Computed Bone Mineralometry (DXA) as an Aid to Pre and Post Assessment in Hip Arthroplasty Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hip osteoarthritis is nowadays one of the most prevalent diseases in developed countries. Prosthetic replacement of the degenerated joint is the definitive treatment for more advanced stages of osteoarthritis.
Despite continuous improvements in prosthesis material, design, and implantation procedures that have led to a percentage reduction in failures, there is still an albeit low risk of hip prosthetic implantation failure today.
Preoperative planning is therefore a prerequisite in order to ensure the success of the implant and its longterm survival. This is generally based on radiographic investigations, with implant selection being based on "templating" the radiographs to replicate the patient's joint anatomy.
However, with preoperative radiographs (or possibly second-level investigations such as CT scans), only the geometry of the bone subjected to the implant through is evaluated, without obtaining information regarding the bone density or the load to which the implant will be subjected. However, the long-term stability of the implant depends on the load transfer to the adjacent bone. Non-physiological load transfer can cause stress-shielding, bone resorption, or fibrous tissue growth due to high micromovements at the implant-bone interface.
The study of images by finite element analysis (FEA) has been used in orthopedic biomechanics for fifty years, and the techniques have progressively evolved in terms of sophistication and ability to assess the postoperative mechanical environment The Bone Strain Index (BSI) software, obtained from computerized bone mineral imaging (DXA) surveys using FEA, automatically calculates the deformations and stresses to which a given bone segment is subjected from patient-specific loading conditions. Previous studies have evaluated changes in periprosthetic bone mineral density (BMD) around hip replacement, noting densitometric changes that could vary between subjects and as a function of treatment, suggesting periprosthetic DXA as a useful technique in early assessment of possible bone loss from periprosthetic resorption. However, there are no DXA-based studies in the literature that correlate BMD changes to periprosthetic mechanical stress.
In this study, the investigators aim to study periprosthetic hip bone by DXA technique, applying the FEA method to obtain two-dimensional models of bone resistance to loading, using BSI software.
This evaluation will be included in the context of the normal pre- and postoperative evaluation process, with a view to better understanding the therapeutic outcome and possibly providing a means of predicting early mobilization and thus possible surgical failure.
Patients will be recruited as part of the normal surgical procedure for patients referred for hip replacement surgery to be performed at the Galeazzi - Sant'Ambrogio Hospital. Subjects, after being informed about the study and giving their written informed consent, will provide the examining physician with the information needed to fill out appropriate biographical and medical history forms. Recruitment will be entrusted to the physicians who will perform routine clinical examinations.
Once enrolled, patients will have a lumbar and femoral DXA scan as a preoperative preliminary investigation; anthropometric evaluations, postoperative DXA scans (immediate postoperative and at 3,6,12 months), blood draws, and PROMs will be administered for each patient. The study will be conducted according to the guidelines of Good Clinical Practices
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laura Mangiavini
- Phone Number: 0283506790
- Email: laura.mangiavini@unimi.it
Study Locations
-
-
-
Milan, Italy, 20173
- Recruiting
- IRCCS Ospedale Galeazzi-Sant'Ambrogio
-
Contact:
- Laura Mangiavini
- Phone Number: 0283506790
- Email: laura.mangiavini@unimi.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients who are candidates for elective hip arthroplasty surgery (indication determined only by the Orthopedic Surgeon)
- Patients with noninflammatory degenerative hip joint disease, including osteoarthritis and the outcomes of congenital hip dysplasia.
- Hip joint deformity correction surgery
- Patients aged 50 to 90 years (completed)
- 18 ≤ Body Mass Index (BMI) ≤ 35 kg/m2
- Postmenopausal women (absence of menstrual cycle for at least 2 years)
- Willingness and ability to provide informed consent
Exclusion Criteria:
Taking drugs that may interfere with muscle or bone metabolism,
- Evidence of diseases known to interfere with bone or muscle metabolism
- Rheumatoid arthritis
- Patients undergoing revision hip replacement surgery
- Presence of infection or suspicion of infection at the hip
- Inability to provide informed consent
- Previous synthetic surgery for proximal femur fractures
- Severe obesity (BMI >35kg/m2)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hip arthroplasty group
This single group is composed by patients undergoing hip arthroplasty
|
Patients will undergo a femoral and lumbar DXA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Role of two-dimensional FEM models obtained from DXA images in longitudinal evaluation of periprosthetic bone
Time Frame: 12 months
|
The purpose of this study is to investigate the role of two-dimensional FEM models obtained from DXA images in longitudinal evaluation of periprosthetic bone, in subjects undergoing hip arthroplasty. Specifically, the study will focus on the joint analysis of changes in the parameters of bone mineral density (BMD) [g/cm2] and Bone Strain Index (BSI) at the periprosthetic bone level of the proximal femur in patients undergoing hip implant surgery using DXA, evaluating the densitometric change of these two parameters over time, starting from an immediately postoperative data and verifying the change at 6 months, to follow the patient through the postoperative course. Since there are no longitudinal evaluation studies of periprosthetic stress, measured by finite element analysis with BSI software, it was decided to focus on the variations in BMD as the main result, limiting the observation on the behavior of the BSI parameter with respect to the variations in BMD. |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Role of two-dimensional FEM models of bone resistance to loading
Time Frame: 12 months
|
To investigate the role of two-dimensional FEM models of bone resistance to loading, obtained from DXA scans using BSI software in various femoral and acetabular periprosthetic regions.
|
12 months
|
Identification of mechanical stress
Time Frame: 12 months
|
To identify, by joint assessment of BMD and BSI, which periprosthetic regions are most subjected to mechanical stress by virtue of the presence of the prosthesis, in order to predict possible excessive periprosthetic bone resorption
|
12 months
|
Assesment with PROMs: VAS
Time Frame: 12 months
|
Assessment of patients' health status through the collection of visual analogue scale (VAS).
Will be used a linear scale with no pain at the left border and very serious pain at the right border
|
12 months
|
Assesment with PROMs; HHS
Time Frame: 12 months
|
Assessment of patients' health status through the collection of Harris Hip Score (HHS).
The score is composed by question with multiple choice.
The maximum score possible is 100.
Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.
|
12 months
|
Assesment with PROMs: SF12
Time Frame: 12 months
|
Assessment of patients' health status through the collection of SF12.
The SF-12 is made up of 4 scales (physical functioning, role and physical health, role and emotional state, mental health) measured by 2 items each and 4 scales each measured by one item (physical pain, vitality, social activities and general health).
|
12 months
|
Assesment with PROMs: HOOS PS
Time Frame: 12 months
|
Assessment of patients' health status through the collection of Hip Disability and Osteoarthritis Outcome Score (HOOS PS).
The questionnaire includes just 5 items with 5 response options each.
Only one answer can be selected.
Each of the items is scored from 0 (no health problems) to 4 (severe health problems).
A raw score is generated by summing up all points of the 5 answers (maximum raw score = 20).
|
12 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laura Mangiavini, University of Milan, IRCCS Ospedale Galeazzi-Sant'Ambrogio
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- THA_DXA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Resorption
-
Second Affiliated Hospital, School of Medicine,...RecruitingAlveolar Bone ResorptionChina
-
Aristotle University Of ThessalonikiUniversity Paul Sabatier of ToulouseRecruiting
-
Nourhan M.AlyAlexandria UniversityCompletedMandibular Bone ResorptionEgypt
-
Marmara UniversityCompleted
-
Egyptian Russian UniversityCompletedAlveolar Bone ResorptionEgypt
-
Cairo UniversityUnknown
-
Cairo UniversityUnknown
-
International Advanced Dentistry, LisbonUnknownBone Loss | Alveolar Bone Resorption
-
University of LouisvilleBioHorizons, Inc.RecruitingAlveolar Bone ResorptionUnited States
-
Universitaire Ziekenhuizen KU LeuvenCompleted
Clinical Trials on DXA
-
Tongji HospitalUnknownChronic Kidney Disease-Mineral and Bone DisorderChina
-
Sheffield Children's NHS Foundation TrustUniversity of SheffieldCompleted
-
Swiss Paraplegic Research, NottwilCompleted
-
Centre Hospitalier Universitaire de NīmesDMS ApelemActive, not recruiting
-
State University of New York - Upstate Medical...CompletedRegional Osteoporosis as a Result of ChemotherapyUnited States
-
Assiut UniversityNot yet recruiting
-
Dionyssiotis, Yannis, M.D.University of ThessalyCompleted
-
Jens Rikardt AndersenHillerod Hospital, DenmarkCompleted
-
Central Hospital, Nancy, FranceUnknown
-
Herlev HospitalDanish Cancer SocietyCompletedDepression | Melanoma | Quality of Life | Pain | Cicatrix | Lymphedema | AnxietyDenmark